Home/ Supplements/ Electrolytes/ Intestinal Formula

Intestinal Formula

product on market Tablet or Pill CVS Health Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 14% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Magnesium hydroxide is supported by strong evidence for its use as an osmotic laxative to relieve constipation. The proprietary mucilage blend and burdock root extract have limited research regarding intestinal health. Overall, these ingredients are generally recognized as safe for short-term use.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Intestinal Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
11
Servings
Other Combinations
Product Type
14%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
2.6 Gram(s)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
Proprietary Mucilage Blend
650 mg
Market median: 425.0mg (88 products)
Proprietary Soothing Blend
150 mg
Red Clover blossom extract
100 mg

Other Ingredients

Cellulose Stearic Acid modified Cellulose Gum Modified Cellulose Magnesium Stearate Vegetable Glycerin Silicon Dioxide Soy Lecithin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendation: Day 1 through 7: three tablets at bedtime with 8 ounces of water. Day 8 through 14: two tablets at bedtime with 8 ounces of water.

Warnings & Precautions

Warning: Do not use this product if pregnant, nursing, have diabetes, or under the age of 12.

Warning: Do not use this product if pregnant, nursing, have diabetes, or under the age of 12.

Do not exceed recommended dose of three tablets in a 24 hour period, or take longer than the maximum dosage for more than two weeks as frequent or prolonged use may result in dependence. Do not use when abdominal pain, nausea or vomiting are present. Consult a healthcare professional if you notice a sudden change in bowel habits that persist over two weeks. Rectal bleeding or failure to move bowels after use may indicate a serious condition. Discontinue use and consult a healthcare professional.

If taking any medications, consult a healthcare professional before use.

Reduce dosage if you experience abdominal discomfort or diarrhea. If discomfort persists, discontinue use.

Formulation Notes

Contains no sugar, salt, yeast, wheat, gluten, dairy products, artificial colors, flavors, preservatives or ingredients of animal origin.

~ No harsh ingredients

~ Vegetarian

Additional Information

LS98967CV . A03 BLK896A

Not for individual sale

Gentle

Cleansing herbal blend ~ Supports comfortable elimination

Metadata

Product Details

DSLD Entry Date2017-07-25
Product TypeOther Combinations
FormTablet or Pill
BrandCVS Health
DSLD ID76542
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

Magnesium
Vitabase · Tablet or Pill
100
Natural Magnesium 250 mg
Sunmark · Tablet or Pill
100
Magnesium 250 mg USP
Equaline · Tablet or Pill
100
Magnesium-Oxide
Genesis Products · Tablet or Pill
100
Calcium Pyruvate 750 mg
Martin Avenue Pharmacy · Tablet or Pill
100
View all Electrolytes products →
Electrolytes research Best Electrolytes All Electrolytes products More from CVS Health View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.